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Abstract Cerebral deposition of [~A4 (~-amyloid) peptide is a 
major pathological feature of AIzheimer's disease. Although the 
mechanism of [~A4 production from cells has been investigated 
extensively, so far little is known about the catabolism of the 
peptide. We report here that the human neuroblastoma cell line 
SH-SY5Y can rapidly clear [~A4 in the culture medium. The 
clearance was not due to the degradation by extraceilularly 
released protease, but rather due to intracellular degradation 
after cellular uptake. This clearance activity was specific to SH- 
SY5Y cells among several cell types examined. Some of the [~A4- 
derived peptides lacking the N-terminal part of the molecule were 
not catabolized, suggesting a specific interaction between the 
cells and ~A4. Although most of the peptide was degraded after 
uptake, small amounts of peptide was accumulated in insoluble 
fractions of the cells and remained stable for several days. These 
observations uggest that this uptake-degradation activity may 
contribute to AD pathogenesis in two different ways: either to 
prevent the amyloid deposition by reducing extracellular [~A4 
concentrations, or to promote the deposition by producing 
insoluble seeds for amyloid formation. 
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1. Introduction 
Amyloid deposits in the brain are the central neuropatho- 
logical features of Alzheimer's disease (AD). 13A4 (13-amyloid) 
peptide was identified as the major component of these insol- 
uble aggregated structures called senile plaques [1,2]. This 
hydrophobic peptide with 40-42 amino acid residues is pro- 
duced by proteolytic processing of a larger transmembrane 
protein termed amyloid precursor protein (APP) [3]. Point 
mutations in the APP gene and recently identified presenilin 
genes, which are associated with familial AD patients, have 
been found to cause increased production of [3A4, especially 
its 'long-tailed' variant [3A4 1-42 [4~7]. It is also reported that 
transgenic mice expressing the mutant APP protein develop 
the characteristic amyloid pathology of AD [8]. Together with 
the fact that 13A4 deposition is the earliest structural sign of 
AD pathology, which may precede the disease symptoms by 
several decades, it is widely accepted that this molecule plays a 
pathogenic role in AD. 
13A4 was found to be a product of normal cell metabolism 
and is also detected as a soluble molecule in body fluids of 
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both AD patients and healthy controls [9 11]. However, the 
mechanism regulating the in vivo level of [3A4 is not eluci- 
dated. Especially, compared to the cellular synthesis of 13A4, 
very little is known about its catabolism, which can be an- 
other critical factor of plaque formation. Here we show that 
the human neuroblastoma cell line SH-SY5Y cells can rapidly 
degrade [3A4 peptide through a cellular uptake mechanism. 
2. Materials and methods 
2.1. Cell culture 
SH-SY5Y cells [12] were maintained in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 15% fetal calf serum (FCS), 
nonessential mino acids (Sigma, USA), penicillin (50 units/ml) and 
streptomycin (50 lag/ml). Cells were cultured in 25 cm 2 flasks and 
routinely passaged by using trypsin-EDTA solution. N2a cells, 
COS7 cells, and HeLa cells were also maintained in the same medium. 
Cells were subcultured into individual wells of 96-well plates (for 
medium 13A4 analysis) or 24-well plates (for cell-associated 13A4 anal- 
ysis) 1-2 days before the experiments and used at 70-80% confluence 
(approx. 2 × 104 cells/well for 96-well plate and 1 × 105 cells/well for 
24-well plate). 
2.2. Analysis of [~A4 clearance from cell culture medium 
Medium of cells cultured in 96-well plate was replaced with 100 lal 
of fresh DMEM medium (supplemented with 1% FCS) containing 
each ~A4 peptide. Cells were incubated at 37°C in 6% CO2, and at 
each time point, 5 gl of the medium was withdrawn and analyzed by 
Western blotting. 
2.3. Analysis of cell-associated [IA4 
Medium of cells cultured in 24-well plates were replaced with fresh 
DMEM (supplemented with 1% FCS) containing 50 ng/m113A4 1-40 
and incubated for 24 h. Cells were washed with cold PBS (2 ml× 3 
times) and lysed by the addition of 300 111 of ice-cold cell lysis buffer 
(50 mM Tris-HC1 pH 7.4 containing 150 mM NaC1, 1% Nonidet P-40, 
1% Triton X-100, 0.1% SDS, 5 mM EDTA, 2 mM phenylmethane- 
sulfonyl fluoride (PMSF), 0.5 mg/ml eupeptin and 0.5 mg/ml pepsta- 
tin). Samples were transferred to fresh eppendorf tubes, incubated on 
ice for 15 min and centrifuged at 13000 rpm at 4°C for 10 min. 13A4 
in the supernatant (cell lysate) was first immunoprecipitated with anti- 
13A4 monoclonal antibody (clone W0-2 [13]) and protein G-agarose 
(Boehringer Mannheim, Germany), and analyzed by Western blotting. 
[3A4 in the precipitate (cell pellet) was solubilized by the addition of 
3 x sample loading buffer (6% SDS, 15% 2-mercaptoethanol, 30% gly- 
cerol and 0.3 mg/ml bromophenol b ue in 188 mM Tris-HC1, pH 6.8) 
and analyzed by Western blotting. 
2.4. Ana(vsis of the stability of internalized ~A4 
SH-SY5Y cells in 24-well plates were incubated with 50 gg/ml of 
13A4 1-42 in DMEM (supplemented with 1% FCS) for 24 h. Cells were 
washed with fresh DMEM medium (without [~A4) (2 mlX3 times) 
and cultured further for 1 6 days in DMEM (1% FCS) without 
13A4 addition. At each time point, cells in one well were washed 
with cold PBS, lysed and analyzed as described above. 
2.5. Western blotting 
Western blot detection and quantitation of [3A4 was performed as 
described elsewhere [13]. Briefly, heat-denatured samples were sepa- 
rated by 10-20% or 16% Tris-Tricine SDS-PAGE. Proteins were 
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blotted onto nitrocellurose membrane and detected with sequential 
incubation with monoclonal anti-[3A4 antibodies, HRP-labeled anti- 
mouse Ig secondary antibody and ECL detection solution (Amer- 
sham, UK). 13A4 concentrations were quantitated by densitometric 
analysis of the bands using MacBas program (Fuji, Japan). The fol- 
lowing monoclonal ntibodies were used for the detection [13]; clone 
W0-2 (anti-13A4 1-16) for the detection of 13A4 1-40, 1-42 and 1-28; 
clone G2-10 (anti-13A4 C-terminus 40) for the detection of 13A4 6-40 
and 17-40 and clone G2-11 (anti-13A4 C-terminus 42) for the detection 
of 17-42 and internalized ~A4 1-42. 
3. Results 
3.1. Clearance of ~A4 peptides from culture medium of 
SH-SY5 Y cells 
Physiological concentrations of synthetic [3A4 1-40 or 1-42 
were added to the culture medium of SH-SY5Y cells and their 
catabolism was investigated. When the medium, after cultur- 
ing for 2 24 h, was withdrawn and analyzed by Western blot 
assay, we found a marked decrease of ]3A4 bands in a time- 
dependent manner (Fig. IA). Densitometric analysis of the 
bands revealed that more than 70% of the peptides disap- 
peared after 6 h (Fig. 1B). 13A4 produced in vivo (cerebro- 
spinal fluid (CSF) 13A4) was also cleared from the medium 
with a similar time course. When the same amount of [3A4 
1-40 was added to the cell culture conditioned medium and 
incubated in the absence of the cells, the peptide was much 
more stable and about 80% of the peptide remained after 6 h. 
Also, addition of protease inhibitor mixture (0.3 gM aproti- 
nin, 0.2 gM pepstatin, 0.25 gM leupeptin, 130 gM bestatin 
and 600 gM phosphoramidon) to the culture medium did not 
change the cellular clearance rate (data not shown). These 
results suggest hat ]3A4 clearance is not due to the proteolytic 
degradation caused by extracellularly released protease. 
In order to examine the possibilities that disappeared 13A4 is 
adsorbed on the cell surface or accumulates in intracellular 
compartments, we next analyzed cell-associated 13A4. After 
24 h incubation with 50 ng/ml of 13A4 1-40, whole cells were 
lysed and analyzed. Small amounts of peptide were detectable 
both from the lysate (soluble fraction after detergent lysis) 
and the pellet (precipitate after detergent treatment and cen- 
trifugation) (Fig. 2). However, recovered peptide (about 2 pg 
from the lysate and 25 pg from pellet) was much less than the 
total amount of [3A4 that had disappeared from the medium 
(about 5 ng), indicating that the majority of the peptides were 
degraded, presumably intracellularly after cellular uptake. 
3.2. Sequence specificity of [IA4 clearance 
We next used several different [3A4 peptides with N-ter- 
minal or C-terminal deletions and compared their clearance. 
As expected from the results of Fig. 1, only 10-30% of peptide 
remained when 1-40, 1-42 or CSF ~A4 was incubated with 
cells for 6 h. 13A4 1-28 and 17-42 was degraded with similar 
efficiency. In contrast, [3A4 6-40 and 17-40 were found to be 
much more stable and more than 70% peptide remained after 
6 h (Fig. 3). 
3.3. Cell type specificity of ~A4 clearance 
We compared several different cell lines for this 13A4 catab- 
olizing activity. Compared to SH-SY5Y cells, incubation with 
three other cell lines, COS7 (African green monkey epithelial 
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Fig. 1. Clearance of [~A4 from SH-SY5Y cell culture medium. A: Western blot detection of [3A4. (1) Synthetic ~]A4 1-40 (50 ng/ml), (2) 1-42 
(200 ng/ml) or (3) human CSF was incubated with SH-SY5Y cells in 96-well plate (100 pl/well). After 2, 6, and 24 h, 5 pl medium was with- 
drawn and analyzed by Western blotting (stained with W0-2 antibody). (4) 13A4 1-40 (50 ng/ml) was spiked into the conditioned medium of 
SH-SY5Y cells (collected after 24 h culture) and analyzed in parallel. When SH-SY5Y cells were cultured in the absence of exogeneous 13A4, 
no band was detectable after 24 h showing endogeneous 13A4 production from the cells is negligible (data not shown). B: Time course of 13A4 
clearance. [3A4 band was quantitated by densitometric analysis and expressed as % of initial amount. Values are means (+ S.D.) of three as- 
says each. 
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cells), HeLa (human epithelial cells), and N2a (mouse neuro- 
blastoma), all led to much less prominent clearance of ~A4 
from the medium (Fig. 4). When we used differentiated SH- 
SY5Y cells (induced by retinoic acid treatment [14]), we found 
no difference in the clearance rate from non-treated SH-SY5Y 
cells (data not shown). 
3.4. Stability of intracellularly accumulated peptide 
Although most of the ]3A4 was degraded after uptake by 
SH-SY5Y cells, a small amount of peptide was detectable 
intracellularly, as shown in Fig. 2. In order to examine the 
fate of this internalized peptide in more detail, we incubated 
the cells with ~A4 1-42 peptide for 24 h, replaced the medium 
by ~A4-free fresh medium and analyzed the time-dependent 
decrease of the intracellular [3A4. In accordance with the re- 
sults of Fig. 2, uptaken peptide was associated with the in- 
soluble cell pellet rather than detergent solubilized fraction, 
and two closely migrating bands were detected at the position 
of 4 kDa (the same position as synthetic [~A4 1-42) and 3.5 
kDa (Fig. 5). Since we used C-terminal specific antibody for 
the detection here, this lower band presumably represents N- 
terminally truncated form of [3A4. Interestingly, the 4 kDa 
band decreased time-dependently, while the 3.5 kDa band 
was more stable and was detectable ven after 6 days incuba- 
tion without [3A4 in the medium. 
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Fig. 3. Peptide sequence specificity of the clearance. Various differ- 
ent [3A4-derived peptides (50 ng/ml for 1-40, 6-40 and 17-40; 200 
ng/ml for 1-42, 1-28 and 17-42) were incubated with SH-SY5Y cells 
for 6 h and analyzed. ]3A4 in CSF sample and [3A4 1-40 added to 
the conditioned medium (without cells) were also analyzed. Values 
are means (_+ S.D.) of three assays. 
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Fig. 2. Analysis of cell-associated ~A4. SH-SY5Y ceils incubated 
with synthetic ]3A4 1-40 (50 ng/ml) for 24 h were lysed and analysed 
as described in Section 2. Whole sample of immunoprecipitated ly- 
sate (lane 1) and pellet (lane 2) (both derived from one well of the 
cells) was loaded into each lane and analyzed by Western blotting 
(W0-2 staining). High background of lysate sample (> 20 kDa) is 
derived from antibody used for the immuoprecipitation. Upper 
bands of pellet sample are non-specific binding of secondary anti- 
body which were also seen when the primary antibody was omitted 
(data not shown). Aliquots of the medium samples (1 lal medi- 
um = 1/500 volume) before (lane 3) and after (lane 4) the incubation 
were also analyzed. 
4. Discussion 
Since neurons and other cells in the brain are shown to 
produce soluble [3A4 constitutively by normal cell metabo- 
lism, there must be a mechanism which catabolizes [~A4 and 
prevents its excessive accumulation. This clearance of ]3A4 is 
potentially as important as its secretion from cells in the for- 
mation of amyloid plaques. 
There exist only a few studies on the ~A4 degradation i  a 
cell culture system. Naidu et al. reported that proteinases 
released by CHO cells transfected with APP gene can degrade 
[3A4 [15]. The activity was inhibited only by the addition of 
mixed proteinase inhibitors, suggesting that proteinases with 
several different classes are involved. Another recent report 
identified a new serine protease complexed with (z2-macro- 
globulin as a [3A4 degrading enzyme, also using APP-trans- 
fected CHO cells [16]. In both cases, ~A4 was degraded in the 
conditioned medium (in the absence of cells) by a soluble 
protease released into the medium. In our study using SH- 
SY5Y cells, we also detected degradation of ]3A4 in condi- 
tioned medium (Fig. 1). However, we found that ~A4 is 
cleared much more rapidly when incubated in the presence 
of cells. Together with the observations that extracellularly 
added protease inhibitors do not block this degradation and 
that small amounts of peptide can be detected intracellularly, 
we think the clearance is most likely mediated by a cellular 
uptake mechanism. Cellular uptake of ]3A4 has also been re- 
ported previously. Ard et al. showed that rat microglia cells 
can remove [3A4 from the medium and accumulate it inside 
the cells [17]. In that report, however, intracellular accumula- 
tion depended on the presence of FCS and the protease in- 
hibitor leupeptin, which was not required in our experiments. 
In another report, Knauer et al. showed that human skin 
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fibroblasts accumulate [3A4 when cultured with high concen- 
trations of 13A4 1-42 [18], although the peptide clearance from 
the medium was not examined. 
Interestingly, we found a sequence specificity of [3A4 catab- 
olism by SH-SY5Y cells. While [3A4 1-40 and 1-42 disap- 
peared from the medium rapidly, 13A4 6-40 and 17-40 were 
found to be stable. This indicates that the clearance is not due 
to a simple non-specific degradation of low-molecular weight 
peptides. Since we also observed cell-type specificity, we spec- 
ulate that there is a specific interaction between SH-SY5Y 
cells and 13A4. One attractive hypothesis is that SH-SY5Y 
cells express a cell surface receptor which recognizes ~A4, 
and receptor-mediated ndocytosis i involved in the uptake. 
If this is the case, the receptor is speculated to recognize a 
conformational state of [3A4 rather than its primary sequence, 
since both 13A4 1-28 and 17-42 were degraded while 6-40 and 
17-40, which contain the whole overlapping residues of the 
former two peptides (residues 17-28), were not degraded. In 
order to examine the possible existence of a receptor, we used 
higher concentrations of ~A4 1-40, which may saturate the 
binding site. However, we did not observe a decrease of the 
clearance rate even at the highest concentration (50 gg/ml) 
(data not shown). Furthermore, degradation of [3A4 1-40 (ex- 
amined with C40 specific antibody) was not inhibited by com- 
peting ]3A4 1-42 with excess amounts (up to 2000-fold molar 
excess) (data not shown), suggesting that this uptake is not 
mediated by a high-affinity receptor. The precise molecular 
mechanism of this uptake-degradation is an important issue 
to be clarified in future studies. 
If this cellular uptake and degradation of 13A4 also occurs 
in vivo in human brain, we think there are two different pos- 
sible contributions to AD pathogenesis. One simple idea is 
that this cellular uptake activity prevents the deposition of 
~A4 by decreasing its extracellular concentration. In this hy- 
pothesis, deficient uptake will cause an accumulation of [3A4 
which leads to its aggregation and deposition. The other pos- 
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Fig. 4. Cell-type specificity of the clearance. Synthetic [3A4 1-40 (50 
ng/ml) was incubated with each different cell lines (cultured in 96- 
well plate) and time-dependent decrease from the medium was 
measured. Values are means of two assays. 
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Fig. 5. Stability of intracellularly accumulated [3A4. SH-SY5Y cells 
cultured with synthetic 13A4 1-42 (50 ~tg/ml) were further cultured in 
the absence of [3A4 and intracellular [3A4 was analyzed by Western 
blotting using C-terminus pecific antibody (clone G2-11). Day 0 
represents he cells analyzed immediately after the 24 h incubation 
with [3A4 and washing. Only the pellet samples are shown, since 
[3A4 band was not detectable from lysate samples in this assay. 
sibility is that the intracellular insoluble 13A4, which is accu- 
mulated through the uptake, serves as a seed for amyloid 
deposition and promote the plaque formation. By this expla- 
nation, enhanced uptake activity will be a cause of disease. In 
relation to the latter hypothesis, it is highly interesting that 
several recent biochemical and immunohistochemical analyses 
showed that the premature 'diffuse' plaques contain consider- 
able amounts of N-terminally truncate ]3A4 [19-22], which is 
also generated in this cellular uptake experiment. This intra- 
cellular N-terminal processing of 13A4 following cellular up- 
take was also observed by using human skin fibroblast [18]. 
We assume further studies on this phenomenon will provide 
a new insight ifito the mechanism of amyloid formation in 
vivo, eventually leading to novel therapeutic approaches. 
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